Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the clinical response rate to sorafenib when added
to existing endocrine therapy in patients with advanced breast cancer.